Skip to main content
logo
Evoke Pharma, Inc. (EVOK)
Dec 17, 2025 - EVOK was delisted (reason: acquired by QOL Medical)
11.00
+0.04 (0.36%)
Inactive · Last trade price on Dec 16, 2025

Evoke Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
14.4210.255.182.511.620.02
Revenue Growth
67.40%97.84%106.51%55.04%6929.00%-
Gross Profit
13.999.894.982.141.29-0.06
Operating Income
-5.2-5.2-7.43-7.79-8.15-13.05
Net Income
-5.23-5.35-7.79-8.22-8.54-13.15
Earnings Per Share
-0.43-2.81-27.97-31.44-38.16-74.88
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
11.5813.64.749.849.148.07
Total Debt
5.115.1655.135.015.25
Net Cash (Debt)
6.468.44-0.264.714.132.82
Net Cash Growth
1.97%--14.09%46.38%-48.91%
Net Cash Per Share
2.204.43-0.9418.0018.4915.95

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-3.62-5.46-4.98-6.6-12.35-6.63
Free Cash Flow
-3.62-5.46-4.98-6.6-12.35-6.63
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
97.02%96.52%96.10%85.24%79.72%-276.68%
Operating Margin
-36.03%-50.77%-143.44%-310.37%-503.79%-56678.32%
Pretax Margin
-36.27%-52.22%-150.41%-327.83%-527.66%-57144.53%
Profit Margin
-36.27%-52.22%-150.41%-327.83%-527.66%-57144.53%
FCF Margin
0.00%-53.26%-96.22%-262.93%-763.43%-28801.07%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
2.120.640.683.5711.102984.89